Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report

The benefit of lamivudine (LAM) in hepatitis B virus (HBV) infection is compromised by the progressively increasing emergence of drug-resistant mutant strains. Although the addition of adefovir dipivoxil (ADV) usually induces complete suppression of viral replication, primary non-response to ADV in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Micco, Lorenzo, Fiorino, Sirio, Loggi, Elisabetta, Lorenzini, Stefania, Vitale, Giovanni, Cursaro, Carmela, Riili, Anna, Bernardi, Mauro, Andreone, Pietro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3030117/
https://ncbi.nlm.nih.gov/pubmed/21686872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.06.2008.0287
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia